Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Oberg

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
European Journal of Haematology|November 1, 1990
Treatment of myelodysplastic syndromes with retinoic acid and 1 alpha-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study. The Scandinavian Myelodysplasia Group (SMG)E Hellström, K H Robèrt, J Samuelsson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
In vivo distribution of [11C]-busulfan in cynomolgus monkey and in the brain of a human patientM Hassan, G Oberg, K Ericson, et al.
Bone Marrow Transplantation|November 13, 2001
Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipientsM Sandström, M O Karlsson, P Ljungman, et al.
Bone Marrow Transplantation|May 9, 2000
The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicityM Hassan, P Ljungman, O Ringdén, et al.
Acta Obstetricia Et Gynecologica Scandinavica|April 1, 1997
High-dose chemotherapy with autologous stem cell support for the treatment of advanced ovarian cancer--initial experience in Uppsala and TurkuS Grenman, B Tholander, K Remes, et al.
Bone Marrow Transplantation|May 1, 1996
Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML GroupB Simonsson, G Oberg, M Björeman, et al.
European Journal of Haematology|September 13, 2002
Long-term follow-up of patients >or=60 yr old with acute myeloid leukaemia treated with intensive chemotherapyG Oberg, A Killander, M Björeman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemiaB Lönnqvist, B Andersson, M Björkholm, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemiaC Paul, M Björkholm, I Christenson, et al.
Blood|June 25, 1998
Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patientsE Hellström-Lindberg, T Ahlgren, Y Beguin, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
European Journal of Haematology|November 1, 1990
Treatment of myelodysplastic syndromes with retinoic acid and 1 alpha-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study. The Scandinavian Myelodysplasia Group (SMG)E Hellström, K H Robèrt, J Samuelsson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
In vivo distribution of [11C]-busulfan in cynomolgus monkey and in the brain of a human patientM Hassan, G Oberg, K Ericson, et al.
Bone Marrow Transplantation|November 13, 2001
Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipientsM Sandström, M O Karlsson, P Ljungman, et al.
Bone Marrow Transplantation|May 9, 2000
The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicityM Hassan, P Ljungman, O Ringdén, et al.
Acta Obstetricia Et Gynecologica Scandinavica|April 1, 1997
High-dose chemotherapy with autologous stem cell support for the treatment of advanced ovarian cancer--initial experience in Uppsala and TurkuS Grenman, B Tholander, K Remes, et al.
Bone Marrow Transplantation|May 1, 1996
Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML GroupB Simonsson, G Oberg, M Björeman, et al.
European Journal of Haematology|September 13, 2002
Long-term follow-up of patients >or=60 yr old with acute myeloid leukaemia treated with intensive chemotherapyG Oberg, A Killander, M Björeman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemiaB Lönnqvist, B Andersson, M Björkholm, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemiaC Paul, M Björkholm, I Christenson, et al.
Blood|June 25, 1998
Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patientsE Hellström-Lindberg, T Ahlgren, Y Beguin, et al.
Pageof 11